1
|
Kasalović MP, Jelača S, Maksimović-Ivanić D, Lađarević J, Radovanović L, Božić B, Mijatović S, Pantelić NĐ, Kaluđerović GN. Novel diphenyltin(IV) complexes with carboxylato N-functionalized 2-quinolone ligands: Synthesis, characterization and in vitro anticancer studies. J Inorg Biochem 2024; 250:112399. [PMID: 37890233 DOI: 10.1016/j.jinorgbio.2023.112399] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Revised: 09/04/2023] [Accepted: 10/09/2023] [Indexed: 10/29/2023]
Abstract
Three new diphenyltin(IV) complexes, bis(3-(4-methyl-2-oxoquinolinyl-1(2H)-yl)propanoato)diphenyltin(IV) (1), bis(2-(4-methyl-2-oxoquinolin-1(2H)-yl)ethanoato)diphenyltin(IV) (2), and bis(2-(4-hydroxy-2-oxoquinolin-1(2H)-yl)ethanoato)diphenyltin(IV) (3), were synthesized and characterized by elemental microanalysis, FT-IR spectroscopy, and multinuclear (1H, 13C and 119Sn) NMR spectroscopy. Crystal structure of ligand precursor, 2-(4-methyl-2-oxoquinolinyl-1-(2H)-yl)acetic acid (HL2), has been determined by X-ray diffraction studies. Asymmetric bidentate coordination of the carboxylato ligands and skew trapezoidal structures are assumed for the synthesized complexes. In vitro anticancer activity of the synthesized diphenyltin(IV) complexes was evaluated against three human: MCF-7 (breast adenocarcinoma), A375 (melanoma), HCT116 (colorectal carcinoma), and three mouse tumor cell lines: 4T1 (breast carcinoma), B16 (melanoma), CT26 (colon carcinoma) using MTT and CV assays. The IC50 values fall in the range from 0.1 to 3.7 μM. Flow cytometric analysis and fluorescent microscopy suggest that complex 1 induces caspase-dependent apoptosis followed with strong blockade of cell division in HCT116 cells. Since complex 1 showed ROS/RNS scavenging potential mentioned cytotoxicity was not connected with oxidative stress.
Collapse
Affiliation(s)
- Marijana P Kasalović
- Department of Engineering and Natural Sciences, University of Applied Sciences Merseburg, Eberhard-Leibnitz-Straße 2, 06217 Merseburg, Germany; Department of Chemistry, Faculty of Science, University of Kragujevac, Radoja Domanovića 12, 34000 Kragujevac, Serbia
| | - Sanja Jelača
- Department of Immunology, Institute for Biological Research "Siniša Stanković" ̶ National Institute of the Republic of Serbia, University of Belgrade, Bulevar despota Stefana 142, 11060 Belgrade, Serbia
| | - Danijela Maksimović-Ivanić
- Department of Immunology, Institute for Biological Research "Siniša Stanković" ̶ National Institute of the Republic of Serbia, University of Belgrade, Bulevar despota Stefana 142, 11060 Belgrade, Serbia
| | - Jelena Lađarević
- Faculty of Technology and Metallurgy, University of Belgrade, Karnegijeva 4, 11000 Belgrade, Serbia
| | - Lidija Radovanović
- Innovation Centre of the Faculty of Technology and Metallurgy, University of Belgrade, Karnegijeva 4, 11000 Belgrade, Serbia
| | - Bojan Božić
- Institute of Physiology and Biochemistry "Ivan Djaja", Faculty of Biology, University of Belgrade, Studentski trg 16, Belgrade 11000, Serbia
| | - Sanja Mijatović
- Department of Immunology, Institute for Biological Research "Siniša Stanković" ̶ National Institute of the Republic of Serbia, University of Belgrade, Bulevar despota Stefana 142, 11060 Belgrade, Serbia
| | - Nebojša Đ Pantelić
- Department of Engineering and Natural Sciences, University of Applied Sciences Merseburg, Eberhard-Leibnitz-Straße 2, 06217 Merseburg, Germany; Department of Chemistry and Biochemistry, Faculty of Agriculture, University of Belgrade, Nemanjina 6, 11080 Belgrade, Serbia.
| | - Goran N Kaluđerović
- Department of Engineering and Natural Sciences, University of Applied Sciences Merseburg, Eberhard-Leibnitz-Straße 2, 06217 Merseburg, Germany.
| |
Collapse
|
2
|
Someșan A, Vieriu S, Crăciun A, Silvestru C, Chiroi P, Nutu A, Jurj A, Lajos R, Berindan‐Neagoe I, Varga RA. C
,
O
‐Chelated organotin(IV) derivatives as potential anticancer agents: Synthesis, characterization, and cytotoxic activity. Appl Organomet Chem 2022. [DOI: 10.1002/aoc.6540] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Adrian‐Alexandru Someșan
- Supramolecular Organic and Organometallic Chemistry Centre, Department of Chemistry and Chemical Engineering Babeș‐Bolyai University Cluj‐Napoca Romania
| | - Sabina‐Mădălina Vieriu
- Supramolecular Organic and Organometallic Chemistry Centre, Department of Chemistry and Chemical Engineering Babeș‐Bolyai University Cluj‐Napoca Romania
| | - Alexandru Crăciun
- Supramolecular Organic and Organometallic Chemistry Centre, Department of Chemistry and Chemical Engineering Babeș‐Bolyai University Cluj‐Napoca Romania
| | - Cristian Silvestru
- Supramolecular Organic and Organometallic Chemistry Centre, Department of Chemistry and Chemical Engineering Babeș‐Bolyai University Cluj‐Napoca Romania
| | - Paul Chiroi
- Research Center for Functional Genomics, Biomedicine and Translational Medicine Iuliu Hatieganu University of Medicine and Pharmacy Cluj‐Napoca Romania
| | - Andreea Nutu
- Research Center for Functional Genomics, Biomedicine and Translational Medicine Iuliu Hatieganu University of Medicine and Pharmacy Cluj‐Napoca Romania
| | - Ancuta Jurj
- Research Center for Functional Genomics, Biomedicine and Translational Medicine Iuliu Hatieganu University of Medicine and Pharmacy Cluj‐Napoca Romania
| | - Raduly Lajos
- Research Center for Functional Genomics, Biomedicine and Translational Medicine Iuliu Hatieganu University of Medicine and Pharmacy Cluj‐Napoca Romania
| | - Ioana Berindan‐Neagoe
- Research Center for Functional Genomics, Biomedicine and Translational Medicine Iuliu Hatieganu University of Medicine and Pharmacy Cluj‐Napoca Romania
| | - Richard A. Varga
- Supramolecular Organic and Organometallic Chemistry Centre, Department of Chemistry and Chemical Engineering Babeș‐Bolyai University Cluj‐Napoca Romania
| |
Collapse
|
3
|
Dodokhova MA, Safronenko AV, Kotieva IM, Alkhuseyn-Kulyaginova MS, Shpakovsky DB, Milaeva ER. Impact of organotin compounds on the growth of epidermoid Lewis carcinoma. RESEARCH RESULTS IN PHARMACOLOGY 2021. [DOI: 10.3897/rrpharmacology.7.71455] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Introduction: Search for new compounds with a broad antitumor and antimetastatic potency due to multiple targeting remains important in medicinal chemistry, pharmacology and oncology. We report the efficacy of hybrid organotin agents bis-(3,5-di-tert-butyl-4-hydroxyphenylthiolate) dimethyltin (Ме3) and (3,5-di-tert-butyl-4-hydroxyphenylthiolate) triphenyltin (Ме5).
Materials and methods: The compounds were administered to mice bearing the spontaneously metastatic epidermoid Lewis lung carcinoma (LLC). The efficacy of the treatment was evaluated by mean life span, percentage of tumor growth inhibition, number of lung metastases, frequency of metastasis, tumor weight 21 days after tumor cell inoculation, and a degree of lung damage according to the method of D. Tarin and J.E. Price.
Results and discussion: For new organotin compounds containing an antioxidant protective fragment of 2,6-di-tert-butylphenol, moderate antitumor and pronounced antimetastatic effects were revealed in the Lewis model of epidermoid lung carcinoma; more active for Me5. Some features of the development of the process of metastasis were recorded with the introduction of various doses of hybrid organotin compounds.
Conclusion: Substances Ме3 and Ме5 possess specific activity on the model under investigation, which allows one to suggest these organotins as promising series of antitumor and antimetastatic agents with multiple targeting mode of action.
Collapse
|
4
|
Jain N, Utreja D, Kaur K, Jain P. Novel Derivatives of Nicotinic Acid as Promising Anticancer Agents. Mini Rev Med Chem 2021; 21:847-882. [PMID: 33200708 DOI: 10.2174/1389557520666201116144756] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2020] [Revised: 08/12/2020] [Accepted: 08/20/2020] [Indexed: 11/22/2022]
Abstract
BACKGROUND Cancer has become the second leading cause of death worldwide. Despite of the availability of significant number of anticancer agents, cancer is still incurable especially at the last stages. Remarkable targets for anticancer research and drug discovery are heterocyclic compounds, and among them, superior effect has been shown by the nitrogen containing compounds than non-nitrogen containing compounds. Nicotinic acid, a nitrogen containing moiety and its derivatives have gained an immense importance in the development of anticancer drugs owing to the wide variety of biological properties displayed by them. OBJECTIVE The objective of this review is to provide researchers the information about various synthetic approaches used for the synthesis of anticancer drugs of nicotinic acid from 2001 onwards and to reveal their application and importance in the treatment of this dreadful disease. CONCLUSION As indicated by this review, considerable work has been done in terms of synthesis and investigation of anticancer potential of nicotinamide derivatives. The information provided in this article may be of great value for the researchers seeking to develop efficient anticancer drugs.
Collapse
Affiliation(s)
- Nisha Jain
- Department of Chemistry, College of Basic Sciences & Humanities, Punjab Agricultural University, Ludhiana, India
| | - Divya Utreja
- Department of Chemistry, College of Basic Sciences & Humanities, Punjab Agricultural University, Ludhiana, India
| | - Komalpreet Kaur
- Department of Chemistry, College of Basic Sciences & Humanities, Punjab Agricultural University, Ludhiana, India
| | - Palak Jain
- Department of Chemistry, College of Basic Sciences & Humanities, Punjab Agricultural University, Ludhiana, India
| |
Collapse
|
5
|
Syed Annuar SN, Kamaludin NF, Awang N, Chan KM. Cellular Basis of Organotin(IV) Derivatives as Anticancer Metallodrugs: A Review. Front Chem 2021; 9:657599. [PMID: 34368075 PMCID: PMC8342812 DOI: 10.3389/fchem.2021.657599] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2021] [Accepted: 06/21/2021] [Indexed: 12/25/2022] Open
Abstract
Organotin(IV) compounds have wide applications in industrial and agricultural fields owing to their ability to act as poly(vinyl chloride) stabilizers and catalytic agents as well as their medicinal properties. Moreover, organotin(IV) compounds may have applications as antitumor, anti-inflammatory, antifungal, or antimicrobial agents based on the observation of synergistic effects following the binding of their respective ligands, resulting in the enhancement of their biological activities. In this review, we describe the antiproliferative activities of organotin(IV) compounds in various human cancer cell lines based on different types of ligands. We also discuss the molecular mechanisms through which organotin(IV) compounds induce cell death via apoptosis through the mitochondrial intrinsic pathway. Finally, we present the mechanisms of cell cycle arrest induced by organotin(IV) compounds. Our report provides a basis for studies of the antitumor activities of organotin(IV) compounds and highlights the potential applications of these compounds as anticancer metallodrugs with low toxicity and few side effects.
Collapse
|
6
|
Anasamy T, Chee CF, Wong YF, Heh CH, Kiew LV, Lee HB, Chung LY. Triorganotin complexes in cancer chemotherapy: Mechanistic insights and future perspectives. Appl Organomet Chem 2020. [DOI: 10.1002/aoc.6089] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- Theebaa Anasamy
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy University of Malaya Kuala Lumpur Malaysia
| | - Chin Fei Chee
- Nanotechnology and Catalysis Research Centre University of Malaya Kuala Lumpur Malaysia
| | - Yuen Fei Wong
- Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy University of Malaya Kuala Lumpur Malaysia
| | - Choon Han Heh
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy University of Malaya Kuala Lumpur Malaysia
| | - Lik Voon Kiew
- Department of Pharmacology, Faculty of Medicine University of Malaya Kuala Lumpur Malaysia
| | - Hong Boon Lee
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy University of Malaya Kuala Lumpur Malaysia
- School of Biosciences, Faculty of Health and Medical Sciences Taylor's University Subang Jaya Selangor Malaysia
| | - Lip Yong Chung
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy University of Malaya Kuala Lumpur Malaysia
| |
Collapse
|
7
|
Anasamy T, Chee CF, Kiew LV, Chung LY. In vivo antitumour properties of tribenzyltin carboxylates in a 4T1 murine metastatic mammary tumour model: Enhanced efficacy by PLGA nanoparticles. Eur J Pharm Sci 2019; 142:105140. [PMID: 31704345 DOI: 10.1016/j.ejps.2019.105140] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2019] [Revised: 10/11/2019] [Accepted: 11/04/2019] [Indexed: 01/26/2023]
Abstract
This study reports the in vivo performance of two tribenzyltin carboxylate complexes, tri(4-fluorobenzyl)tin[(N,N-diisopropylcarbamothioyl)sulfanyl]acetate (C1) and tribenzyltin isonicotinate (C9), in their native form as well as in a poly(lactic-co-glycolic acid) (PLGA)-based nanoformulation, to assess their potential to be translated into clinically useful agents. In a 4T1 murine metastatic mammary tumour model, single intravenous administration of C1 (2.7 mg/kg) and C9 (2.1 mg/kg; 2.1 mg/kg C9 is equivalent to 2.7 mg/kg C1) induced greater tumour growth delay than cisplatin and doxorubicin at equivalent doses, while a double-dose regimen demonstrated a much greater tumour growth delay than the single-dose treated groups. To improve the efficacy of the complexes in vivo, C1 and C9 were further integrated into PLGA nanoparticles to yield nanosized PLGA-C1 (183.7 ± 0.8 nm) and PLGA-C9 (163.2 ± 1.2 nm), respectively. Single intravenous administration of PLGA-C1 (2.7 mg C1 equivalent/kg) and PLGA-C9 (2.1 mg C9 equivalent/kg) induced greater tumour growth delay (33% reduction in the area under curve compared to that of free C1 and C9). Multiple-dose administration of PLGA-C1 (5.4 mg C1 equivalent/kg) and PLGA-C9 (4.2 mg C9 equivalent/kg) induced tumour growth suppression at the end of the study (21.7 and 34.6% reduction relative to the size on day 1 for the double-dose regimen; 73.5 and 79.0% reduction relative to the size on day 1 for the triple-dose regimen, respectively). Such tumour growth suppression was not observed in mice receiving multiple-dose regimens of free C1 and C9. Histopathological analysis revealed that metastasis to the lung and liver was inhibited in mice receiving PLGA-C1 and PLGA-C9. The current study has demonstrated the improved in vivo antitumour efficacies of C1 and C9 compared with conventional chemotherapy drugs and the enhancement of the efficacies of these agents via a robust PLGA-based nanoformulation and multiple-drug administration approach.
Collapse
Affiliation(s)
- Theebaa Anasamy
- Department of Pharmacy, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
| | - Chin Fei Chee
- Nanotechnology and Catalysis Research Centre, University of Malaya, 50603 Kuala Lumpur, Malaysia
| | - Lik Voon Kiew
- Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
| | - Lip Yong Chung
- Department of Pharmacy, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.
| |
Collapse
|
8
|
Verginadis II, Karkabounas SC, Simos YV, Velalopoulou AP, Peschos D, Avdikos A, Zelovitis I, Papadopoulos N, Dounousi E, Ragos V, Evangelou AM. Antitumor effects of the electromagnetic resonant frequencies derived from the 1H NMR spectrum of Ph 3Sn(Mercaptonicotinic)SnPh 3 complex. Med Hypotheses 2019; 133:109393. [PMID: 31563097 DOI: 10.1016/j.mehy.2019.109393] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2019] [Revised: 09/01/2019] [Accepted: 09/05/2019] [Indexed: 10/26/2022]
Abstract
The aim of this article is to investigate the potential cytotoxic and antitumor effects of the resonant electromagnetic fields (rEMFs) derived from the 1H NMR spectrum of the Ph3Sn(Mercaptonicotinic)SnPh3 complex (SnMNA). The ability of the complex's rEMFs to induce leiomyosarcoma (LMS) cell death and to recess tumor (leiomyosarcoma) development in Wistar rats was evaluated. The effects of the simultaneous administration of the SnMNA complex at extremely low concentrations and exposure to its rEMFs was also investigated. The emission of the 1H NMR spectrum of the complex alone or in a combination with low ineffective doses of the complex decreased LMS cell viability mainly through apoptosis. Moreover, the results from the in vivo experiments showed a significant prolongation of life expectancy in tumor-bearing rats exposed to the rEMFs alongside a deceleration in tumor growth rate. We speculate that the rEMFs of a biologically active substance could exert similar biological effects as the substance itself, mainly when is combined with extremely low ineffective concentrations of the substance.
Collapse
Affiliation(s)
- Ioannis I Verginadis
- Department of Physiology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece
| | - Spyridon Ch Karkabounas
- Department of Physiology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece
| | - Yannis V Simos
- Department of Physiology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece
| | - Anastasia P Velalopoulou
- Department of Physiology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece
| | - Dimitrios Peschos
- Department of Physiology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece
| | - Antonis Avdikos
- Department of Physiology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece
| | - Ioannis Zelovitis
- Department of Physiology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece
| | - Nikolaos Papadopoulos
- Department of Physiology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece
| | - Evangelia Dounousi
- Department of Nephrology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece
| | - Vasilios Ragos
- Clinic of Maxillofacial Surgery, Medical Department, University of Ioannina, Ioannina 45110, Ioannina, Greece
| | - Angelos M Evangelou
- Department of Physiology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
| |
Collapse
|
9
|
I. M, Raza MK, Shahid M, Ansari A, Ahmad M, Khan IM. Unprecedented isolation of a dinuclear tin (II) complex stabilized by pyridine‐2,6‐dimethanol: structure, DFT and in vitro screening of cytotoxic properties. Appl Organomet Chem 2019. [DOI: 10.1002/aoc.5006] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Affiliation(s)
- Mantasha I.
- Department of ChemistryAligarh Muslim University Aligarh India
| | - Md Kausar Raza
- Department of Inorganic and Physical ChemistryIndian Institute of Science Bangaluru India
| | - M. Shahid
- Department of ChemistryAligarh Muslim University Aligarh India
| | - Azaj Ansari
- Department of ChemistryCentral University of Haryana Mahendergarh India
| | - Musheer Ahmad
- Department of Applied Chemistry, ZHCETAligarh Muslim University Aligarh India
| | - Ishaat M. Khan
- Department of ChemistryAligarh Muslim University Aligarh India
| |
Collapse
|
10
|
Banti CN, Hadjikakou SK, Sismanoglu T, Hadjiliadis N. Anti-proliferative and antitumor activity of organotin(IV) compounds. An overview of the last decade and future perspectives. J Inorg Biochem 2019; 194:114-152. [PMID: 30851663 DOI: 10.1016/j.jinorgbio.2019.02.003] [Citation(s) in RCA: 64] [Impact Index Per Article: 12.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2018] [Revised: 02/06/2019] [Accepted: 02/08/2019] [Indexed: 01/06/2023]
Abstract
Organotins(IV) exhibit significant in vitro anti-proliferative activity, while the in vivo tests are encouraging. The recent reports on the anti-proliferative activity of organotin(IV) compounds are summarized in this review. The period covered by this work goes back to 2009 until late 2018, while the earlier ones, are included over the previous review of our group published by S.K. Hadjikakou, N. Hadjiliadis, in Coord Chem Rev, 253 (2009) 235-249. During the last decade (2009-2018), >300 organotin(IV) derivatives with oxygen-donor ligands, such as carboxylic acids, amino-acids, Non Steroidal Anti-inflammatory Drugs (NSAIDs), biological active derivatives or natural products, organotins(IV) with sulfur containing ligands such as thiones, thiosemicarbazones, dithiocarbamates, organotin(IV) compounds of oximes and organotins(IV) with amines or semicarbazones were screened for their anti-proliferative effect against various cancer cell lines and their results are included in numerous reports over this period. Although much work has been carried out on organotin(IV) derivatives with O-donor ligands, however significant fewer reports are found on organotins(IV) with oximes as ligands.
Collapse
Affiliation(s)
- Christina N Banti
- Section of Inorganic and Analytical Chemistry, Department of Chemistry, University of Ioannina, 45110 Ioannina, Greece
| | - Sotiris K Hadjikakou
- Section of Inorganic and Analytical Chemistry, Department of Chemistry, University of Ioannina, 45110 Ioannina, Greece.
| | - Tuba Sismanoglu
- Istanbul University, Engineering Faculty, Department Chemistry, Istanbul, Turkey
| | - Nick Hadjiliadis
- Section of Inorganic and Analytical Chemistry, Department of Chemistry, University of Ioannina, 45110 Ioannina, Greece.
| |
Collapse
|
11
|
Arora R, Issar U, Kakkar R. Theoretical investigation of organotin(IV) complexes of substituted benzohydroxamic acids. COMPUT THEOR CHEM 2018. [DOI: 10.1016/j.comptc.2018.06.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
12
|
Latsis GK, Banti CN, Kourkoumelis N, Papatriantafyllopoulou C, Panagiotou N, Tasiopoulos A, Douvalis A, Kalampounias AG, Bakas T, Hadjikakou SK. Poly Organotin Acetates against DNA with Possible Implementation on Human Breast Cancer. Int J Mol Sci 2018; 19:ijms19072055. [PMID: 30011935 PMCID: PMC6073380 DOI: 10.3390/ijms19072055] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2018] [Revised: 07/06/2018] [Accepted: 07/12/2018] [Indexed: 11/16/2022] Open
Abstract
Two known tin-based polymers of formula {[R3Sn(CH3COO)]n} where R = n-Bu– (1) and R = Ph– (2),were evaluated for their in vitro biological properties. The compounds were characterized via their physical properties and FT-IR, 119Sn Mössbauer, and 1H NMR spectroscopic data. The molecular structures were confirmed by single-crystal X-Ray diffraction crystallography. The geometry around the tin(IV) ion is trigonal bi-pyramidal. Variations in O–Sn–O···Sn′ torsion angles lead to zig-zag and helical supramolecular assemblies for 1 and 2, respectively. The in vitro cell viability against human breast adenocarcinoma cancer cell lines: MCF-7 positive to estrogens receptors (ERs) and MDA-MB-231 negative to ERs upon their incubation with 1 and 2 was investigated. Their toxicity has been studied against normal human fetal lung fibroblast cells (MRC-5). Compounds 1 and 2 exhibit 134 and 223-fold respectively stronger antiproliferative activity against MDA-MB-231 than cisplatin. The type of the cell death caused by 1 or 2 was also determined using flow cytometry assay. The binding affinity of 1 and 2 towards the CT-DNA was suspected from the differentiation of the viscosity which occurred in the solution containing increasing amounts of 1 and 2. Changes in fluorescent emission light of Ethidium bromide (EB) in the presence of DNA confirmed the intercalation mode of interactions into DNA of both complexes 1 and 2 which have been ascertained from viscosity measurements. The corresponding apparent binding constants (Kapp) of 1 and 2 towards CT-DNA calculated through fluorescence spectra are 4.9 × 104 (1) and 7.3 × 104 (2) M−1 respectively. Finally, the type of DNA binding interactions with 1 and 2 was confirmed by docking studies.
Collapse
Affiliation(s)
- George K Latsis
- Section of Inorganic and Analytical Chemistry, Department of Chemistry, University of Ioannina, 45110 Ioannina, Greece.
| | - Christina N Banti
- Section of Inorganic and Analytical Chemistry, Department of Chemistry, University of Ioannina, 45110 Ioannina, Greece.
| | - Nikolaos Kourkoumelis
- Medical Physics Laboratory, Medical School, University of Ioannina, 45110 Ioannina, Greece.
| | | | - Nikos Panagiotou
- Department of Chemistry, University of Cyprus, 1678 Nicosia, Cyprus.
| | | | - Alexios Douvalis
- Mössbauer Spectroscopy and Physics of Material Laboratory, Department of Physics, University of Ioannina, 45110 Ioannina, Greece.
| | - Angelos G Kalampounias
- Physical Chemistry Laboratory, Department of Chemistry, University of Ioannina, 45110 Ioannina, Greece.
| | - Thomas Bakas
- Mössbauer Spectroscopy and Physics of Material Laboratory, Department of Physics, University of Ioannina, 45110 Ioannina, Greece.
| | - Sotiris K Hadjikakou
- Section of Inorganic and Analytical Chemistry, Department of Chemistry, University of Ioannina, 45110 Ioannina, Greece.
| |
Collapse
|
13
|
Antonenko T, Shpakovsky D, Vorobyov M, Gracheva Y, Kharitonashvili E, Dubova L, Shevtsova E, Tafeenko V, Aslanov L, Iksanova A, Shtyrlin Y, Milaeva E. Antioxidative vs
cytotoxic activities of organotin complexes bearing 2,6-di-tert
-butylphenol moieties. Appl Organomet Chem 2018. [DOI: 10.1002/aoc.4381] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- T.A. Antonenko
- Department of Medicinal Chemistry and Fine Organic Synthesis; Lomonosov Moscow State University; Moscow 119991 Russia
| | - D.B. Shpakovsky
- Department of Medicinal Chemistry and Fine Organic Synthesis; Lomonosov Moscow State University; Moscow 119991 Russia
| | - M.A. Vorobyov
- Department of Medicinal Chemistry and Fine Organic Synthesis; Lomonosov Moscow State University; Moscow 119991 Russia
| | - Yu.A. Gracheva
- Department of Medicinal Chemistry and Fine Organic Synthesis; Lomonosov Moscow State University; Moscow 119991 Russia
| | - E.V. Kharitonashvili
- Department of Medicinal Chemistry and Fine Organic Synthesis; Lomonosov Moscow State University; Moscow 119991 Russia
| | - L.G. Dubova
- Institute of Physiologically Active Compounds of Russian Academy of Sciences; Chernogolovka 142432 Russia
| | - E.F. Shevtsova
- Institute of Physiologically Active Compounds of Russian Academy of Sciences; Chernogolovka 142432 Russia
| | - V.A. Tafeenko
- Department of Medicinal Chemistry and Fine Organic Synthesis; Lomonosov Moscow State University; Moscow 119991 Russia
| | - L.A. Aslanov
- Department of Medicinal Chemistry and Fine Organic Synthesis; Lomonosov Moscow State University; Moscow 119991 Russia
| | - A.G. Iksanova
- Kazan (Volga Region) Federal University; Kazan 420008 Russia
| | - Yu.G. Shtyrlin
- Kazan (Volga Region) Federal University; Kazan 420008 Russia
| | - E.R. Milaeva
- Department of Medicinal Chemistry and Fine Organic Synthesis; Lomonosov Moscow State University; Moscow 119991 Russia
- Kazan (Volga Region) Federal University; Kazan 420008 Russia
| |
Collapse
|
14
|
Cytotoxic effect, antitumour activity and toxicity of organotin derivatives with ortho- or para-hydroxy-benzoic acids. Med Chem Res 2018. [DOI: 10.1007/s00044-018-2135-7] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
15
|
Milaeva ER, Tyurin VY. Hybrid metal complexes with opposed biological modes of action – promising selective drug candidates. PURE APPL CHEM 2017. [DOI: 10.1515/pac-2016-1130] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
AbstractThe oxidative stress is considered to be involved in the pathogenesis of many diseases. The antioxidative defense system in the living organism regulates the toxic impact of ROS and there is strong evidence that the antioxidants prevent some pathologies including cancer. The specific chemical properties of metal-based drugs impart innovative pharmacological profiles to this type of therapeutic agents, most likely in relation to novel biomolecular mechanisms. This review will focus on a novel approach to design polyfunctional metal-based physiollogically active compounds with opposed modes of action – prooxidant metal center and antioxidant 2,6-dialkylphenol group. The synthesis and anti/prooxidant activity and cytotoxicity studies of novel organometallic/coordination compounds (ferrocenes, complexes with di-(2-picolyl)amine ligand, porphyrins, pyridines, thiols, carboxylates) based on either biogenic metals (Fe, Mn, Co, Cu, Zn, Ni) or exogenic metals (Sn, Au, Rh) are presented and discussed. The results allow us to conclude that combining in one molecule a redox active metal center and cytoprotective functional organic moiety with antioxidative function is a promising way to rational metallodrug design in modern medicinal chemistry.
Collapse
Affiliation(s)
- Elena R. Milaeva
- Moscow State Lomonosov University, Department of Medicinal Chemistry and Fine Organic Synthesis, Lenin Hill 1-3, Moscow 119991, Russian Federation
| | - Vladimir Yu. Tyurin
- Moscow State Lomonosov University, Department of Medicinal Chemistry and Fine Organic Synthesis, Lenin Hill 1-3, Moscow 119991, Russian Federation
| |
Collapse
|
16
|
Ali S, Shahzadi S, Imtiaz-ud-Din. Anticarcinogenicity and Toxicity of Organotin(IV) Complexes: A Review. IRANIAN JOURNAL OF SCIENCE AND TECHNOLOGY, TRANSACTIONS A: SCIENCE 2016. [DOI: 10.1007/s40995-016-0048-1] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
17
|
Milaeva E, Shpakovsky D, Gracheva Y, Antonenko T, Osolodkin D, Palyulin V, Shevtsov P, Neganova M, Vinogradova D, Shevtsova E. Some insight into the mode of cytotoxic action of organotin compounds with protective 2,6-di-tert-butylphenol fragments. J Organomet Chem 2015. [DOI: 10.1016/j.jorganchem.2014.12.013] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
18
|
Nath M, Vats M, Roy P. Design, spectral characterization, anti-tumor and anti-inflammatory activity of triorganotin(IV) hydroxycarboxylates, apoptosis inducers: In vitro assessment of induction of apoptosis by enzyme, DNA-fragmentation, acridine orange and comet assays. Inorganica Chim Acta 2014. [DOI: 10.1016/j.ica.2014.02.034] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
19
|
Amir MK, Khan S, Zia-ur-Rehman, Shah A, Butler IS. Anticancer activity of organotin(IV) carboxylates. Inorganica Chim Acta 2014. [DOI: 10.1016/j.ica.2014.07.053] [Citation(s) in RCA: 80] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
|
20
|
Deb T, Gopal PK, Ganguly D, Das P, Paul M, Saha MB, Paul S, Das S. Enhancement of anti-leukemic potential of 2-hydroxyphenyl-azo-2′-naphthol (HPAN) on MOLT-4 cells through conjugation with Cu(ii). RSC Adv 2014. [DOI: 10.1039/c3ra44765k] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
|
21
|
Shpakovsky DB, Banti CN, Mukhatova EM, Gracheva YA, Osipova VP, Berberova NT, Albov DV, Antonenko TA, Aslanov LA, Milaeva ER, Hadjikakou SK. Synthesis, antiradical activity and in vitro cytotoxicity of novel organotin complexes based on 2,6-di-tert-butyl-4-mercaptophenol. Dalton Trans 2014; 43:6880-90. [DOI: 10.1039/c3dt53469c] [Citation(s) in RCA: 62] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The antiradical activity and in vitro cytotoxicity of novel organotin complexes with 2,6-di-tert-butylphenol pendant were established.
Collapse
Affiliation(s)
- D. B. Shpakovsky
- Moscow State Lomonosov University
- Department of Chemistry
- Moscow, Russian Federation
| | - C. N. Banti
- Section of Inorganic and Analytical Chemistry
- Department of Chemistry
- University of Ioannina
- Ioannina, Greece
| | - E. M. Mukhatova
- Astrakhan’ State Technical University
- Astrakhan’, Russian Federation
| | - Yu. A. Gracheva
- Moscow State Lomonosov University
- Department of Chemistry
- Moscow, Russian Federation
| | - V. P. Osipova
- South Research Center
- Russian Academy of Sciences
- Rostov on Don, Russian Federation
| | - N. T. Berberova
- Astrakhan’ State Technical University
- Astrakhan’, Russian Federation
| | - D. V. Albov
- Moscow State Lomonosov University
- Department of Chemistry
- Moscow, Russian Federation
| | - T. A. Antonenko
- Moscow State Lomonosov University
- Department of Chemistry
- Moscow, Russian Federation
| | - L. A. Aslanov
- Moscow State Lomonosov University
- Department of Chemistry
- Moscow, Russian Federation
| | - E. R. Milaeva
- Moscow State Lomonosov University
- Department of Chemistry
- Moscow, Russian Federation
| | - S. K. Hadjikakou
- Section of Inorganic and Analytical Chemistry
- Department of Chemistry
- University of Ioannina
- Ioannina, Greece
| |
Collapse
|
22
|
Employment of pyridyl oximes and dioximes in zinc(II) chemistry: Synthesis, structural and spectroscopic characterization, and biological evaluation. Inorganica Chim Acta 2013. [DOI: 10.1016/j.ica.2012.09.039] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
23
|
Main-Group Medicinal Chemistry Including Li and Bi*. COMPREHENSIVE INORGANIC CHEMISTRY II 2013. [PMCID: PMC7152213 DOI: 10.1016/b978-0-08-097774-4.00338-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Main-group element compounds were among the first developed in the modern era as pharmaceutical preparations for the treatment of a wide variety of human ailments; it is now recognized that many of these elements exist in traditional medicine of many societies, for example, arsenic. The use of main-group element compounds in contemporary medicine continues for the treatment of, for example, depression (Li), stomach ulcers (Bi), cancer (As and Ga), and leishmaniasis (Sb). Not surprisingly, new compounds of these elements, and other main-group elements, continue to be investigated for their potential use in new therapies. In this chapter, the use of main-group elements as therapeutic agents is outlined and also, where understood, comments on biological targets and mechanisms of action. Further, key advances in new potential applications of main-group element compounds in medicine are evaluated.
Collapse
|
24
|
Badr El-Din AS, Etaiw SEDH, El-Zaria ME. Triphenyltin chloride complexes containing bidentate organodiimines as effective antitumor agents. J COORD CHEM 2012. [DOI: 10.1080/00958972.2012.725846] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- Ahmed S. Badr El-Din
- a Chemistry Department, Faculty of Science , University of Tanta , Tanta , Egypt
| | | | - Mohamed E. El-Zaria
- a Chemistry Department, Faculty of Science , University of Tanta , Tanta , Egypt
| |
Collapse
|
25
|
Cytotoxic and anticancer effects of the triorganotin compound [(C6H5)3Sn(cmbzt)]: An in vitro, ex vivo and in vivo study. Eur J Pharm Sci 2012; 47:490-6. [DOI: 10.1016/j.ejps.2012.07.011] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2012] [Revised: 07/05/2012] [Accepted: 07/05/2012] [Indexed: 11/18/2022]
|
26
|
Shpakovsky DB, Banti CN, Beaulieu-Houle G, Kourkoumelis N, Manoli M, Manos MJ, Tasiopoulos AJ, Hadjikakou SK, Milaeva ER, Charalabopoulos K, Bakas T, Butler IS, Hadjiliadis N. Synthesis, structural characterization and in vitro inhibitory studies against human breast cancer of the bis-(2,6-di-tert-butylphenol)tin(iv) dichloride and its complexes. Dalton Trans 2012; 41:14568-82. [DOI: 10.1039/c2dt31527k] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
|
27
|
Banti CN, Giannoulis AD, Kourkoumelis N, Owczarzak AM, Poyraz M, Kubicki M, Charalabopoulos K, Hadjikakou SK. Mixed ligand–silver(i) complexes with anti-inflammatory agents which can bind to lipoxygenase and calf-thymus DNA, modulating their function and inducing apoptosis. Metallomics 2012; 4:545-60. [DOI: 10.1039/c2mt20039b] [Citation(s) in RCA: 89] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|